| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |